// App-Quantinova.ai

374 : YAP Regulated SOX9 Expression Promotes Liver Fibrosis.

Researchers

Presenter

  • James Pritchett

Principal Investigators

  • Jessica Llewellyn

  • Varinder S. Athwal

  • Katherine Martin

  • Emma Harvey

  • Scott L. Friedman

  • Neil Hanley

  • Karen Piper Hanley

Medical Centers

  • School of Healthcare Science, Manchester Metropolitan University, Manchester, United Kingdom

  • Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, United Kingdom

  • Research & Innovation Division, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

  • Basser Center, University of Pennsylvania, Philadelphia, PA

  • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Department of Histopathology, University Hospital of South Manchester (U.K.), Manchester, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Hepatic fibrosis

Biomarkers

  • Yes Associated Protein 1

Drug/Treatment

  • verteporfin

  • Tamoxifen

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved